This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Pantoprazole Is A Type Of Proton Pump Inhibitor (PPI) Medication Used To Treat Gastroesophageal Reflux Disease (GERD), Erosive Esophagitis, And Hypersecretory Conditions. It Works By Blocking The Release Of Acid In The Stomach, Thus Reducing Acid Levels And Allowing The Esophagus To Heal. Pantoprazole Is Available In Both Intravenous And Oral Forms. Pantoprazole Is Generally Well Tolerated And Is Considered Safe For Short-Term Use. Common Side Effects Of Pantoprazole Include Headache, Nausea, Constipation, Diarrhoea, And Abdominal Pain. Less Common Side Effects Include Dizziness, Rash, And Itching. People With Kidney Or Liver Disease May Be At An Increased Risk Of Adverse Effects. When Used To Treat GERD And Erosive Esophagitis, Pantoprazole Is Usually Taken For A Few Weeks To Several Months. For Hypersecretory Conditions, Pantoprazole May Be Taken For Up To A Year. Pantoprazole Should Not Be Taken For Longer Than Recommended By A Healthcare Provider As It May Cause Vitamin B12 Deficiency And Other Serious Side Effects. For People With GERD And Erosive Esophagitis, Pantoprazole May Be Used In Combination With Lifestyle Changes, Such As Avoiding Caffeine, Avoiding Alcohol, Eating Smaller Meals, And Avoiding Lying Down For 3 Hours After Eating. Additionally, People Should Talk To Their Healthcare Provider About The Best Ways To Manage Their Symptoms. In General, Pantoprazole Is A Safe And Effective Medication For Treating GERD, Erosive Esophagitis, And Hypersecretory Conditions. However, It Is Important To Follow The Instructions Of A Healthcare Provider And To Seek Medical Attention If Any Serious Side Effects Occur.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States